Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Episode 38

0:00-31:28

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and soul behind rare-disease drug development. From her early days studying electrochemistry at the University of Kansas to leading cutting-edge bioanalytical programs at Ultragenyx, Dr. DeSilva shares how curiosity and community shaped her four-decade career. She discusses the profound responsibility of working with limited, often irreplaceable patient samples with care. A special thanks to AAPS (https://www.aaps.org/) for their help and support of this episode. The conversation dives into: Balancing rigor and agility in small-population clinical studies Leveraging entrepreneurial mindsets from biotech within big pharma frameworks The promise of dried blood spots (DBS) and patient-centric sampling Mentorship, curiosity, and the future of scientific leadership Her return to Sri Lanka with KU faculty to recruit the next generation of scientists Throughout the discussion, DeSilva underscores a recurring theme: science thrives when curiosity meets compassion. This episode is a masterclass in both. Guest Links Dr. Binodh DeSilva https://www.linkedin.com/in/binodh-desilva/ Ultragenyx Pharmaceuticals - https://www.ultragenyx.com/ Hosts Dr.

Publisher

BioTalk Unzipped

Link

biotalk-unzipped.captivate.fm/episode/fail-fast-learn-faster-binodh-desilva-rare-disease-drug-development

Published

October 23, 2025

Duration

31 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Gregory Austin

BU

BioTalk Unzipped

@biotalkunzipped

#learnfaster #drugdevelopment #binodhdesilva #lifesciences #medicine

The Nile